CN105989506A - Drug safety management system and method - Google Patents
Drug safety management system and method Download PDFInfo
- Publication number
- CN105989506A CN105989506A CN201510873882.7A CN201510873882A CN105989506A CN 105989506 A CN105989506 A CN 105989506A CN 201510873882 A CN201510873882 A CN 201510873882A CN 105989506 A CN105989506 A CN 105989506A
- Authority
- CN
- China
- Prior art keywords
- medicine
- subelement
- drug
- doctor
- pharmacist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 221
- 229940079593 drug Drugs 0.000 title claims abstract description 86
- 238000000034 method Methods 0.000 title description 5
- 238000004519 manufacturing process Methods 0.000 claims abstract description 22
- 238000011156 evaluation Methods 0.000 claims abstract description 16
- 230000008520 organization Effects 0.000 claims abstract description 8
- 238000004891 communication Methods 0.000 claims abstract description 4
- 238000007726 management method Methods 0.000 claims description 38
- 239000003962 counterfeit drug Substances 0.000 claims description 18
- 238000012795 verification Methods 0.000 claims description 11
- 238000012544 monitoring process Methods 0.000 claims description 9
- 239000002994 raw material Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 5
- 238000007689 inspection Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 description 18
- 238000011160 research Methods 0.000 description 10
- 238000011084 recovery Methods 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000002354 daily effect Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 206010061623 Adverse drug reaction Diseases 0.000 description 3
- 229940121657 clinical drug Drugs 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000009509 drug development Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000002547 new drug Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 208000011117 substance-related disease Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 206010013654 Drug abuse Diseases 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 206010013663 drug dependence Diseases 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229940124645 emergency medicine Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/018—Certifying business or products
- G06Q30/0185—Product, service or business identity fraud
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q10/00—Administration; Management
- G06Q10/06—Resources, workflows, human or project management; Enterprise or organisation planning; Enterprise or organisation modelling
- G06Q10/067—Enterprise or organisation modelling
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0201—Market modelling; Market analysis; Collecting market data
- G06Q30/0203—Market surveys; Market polls
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q30/00—Commerce
- G06Q30/02—Marketing; Price estimation or determination; Fundraising
- G06Q30/0201—Market modelling; Market analysis; Collecting market data
- G06Q30/0206—Price or cost determination based on market factors
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Information and communication technology [ICT] specially adapted for implementation of business processes of specific business sectors, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Social work or social welfare, e.g. community support activities or counselling services
Landscapes
- Business, Economics & Management (AREA)
- Engineering & Computer Science (AREA)
- Strategic Management (AREA)
- Development Economics (AREA)
- Accounting & Taxation (AREA)
- Entrepreneurship & Innovation (AREA)
- Finance (AREA)
- Economics (AREA)
- General Business, Economics & Management (AREA)
- Marketing (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Theoretical Computer Science (AREA)
- Human Resources & Organizations (AREA)
- Tourism & Hospitality (AREA)
- Game Theory and Decision Science (AREA)
- Data Mining & Analysis (AREA)
- Health & Medical Sciences (AREA)
- Operations Research (AREA)
- Quality & Reliability (AREA)
- Educational Administration (AREA)
- Child & Adolescent Psychology (AREA)
- General Health & Medical Sciences (AREA)
- Primary Health Care (AREA)
- Medical Treatment And Welfare Office Work (AREA)
Abstract
The invention discloses a drug safety management system. The system comprises a user unit (1), a communication unit (2) and an operational management unit (3), wherein the user unit comprises a registration subunit (11), a query subunit (12), a payment subunit (13), an evaluation subunit (14) and a feedback subunit (15); and the operational unit comprises a drug source management subunit (31), a drug circulation state management subunit (32), an organization management subunit (33), a physician management subunit (34), a pharmacist management subunit (35) and an expert supervision subunit (36). According to the system, the transparency of drug production sales and the drug safety can be improved.
Description
Technical field
The present invention relates to drug safety field, be specifically related to a kind of Drug Safety Management system and method.
Background technology
China's pharmaceutical industry has obtained fast development in recent years, has evolved into the big market of trillion scales.But, medicine
Safety problem emerges in an endless stream.Along with the most flourishing of pharmaceutical industry and development, ensure the healthy demand to medicine of the people,
Rationally science management and control drug safety risk, it has also become the maximum cry of the people's livelihood.Counterfeit drug, recovery medicine, Expired drug return to
Market, causes high risks to drug safety；Sham publicity remains incessant after repeated prohibition；High drug price, bribes and sells, constantly aggravate
Conflict between doctors and patients；Drug abuse and over-treatment, i.e. compromise patients ' interest, the most greatly impacted Medical-Care System；No
Good reaction reports and monitors ineffective, seriously constrains drug risk management level, and pharmacovigilance is delayed and grade is too low, no
Can effectively control Adverse drug events.Wicked business gains medicine by cheating and forces down medicine falsifying sale, bribes the very disruptive medicines such as sale
Market order.
The main deficiency of the transaction of existing internet medicine and medicine information service is not have with behavior under solid shop/brick and mortar store in other words line
There is the progress of essence, simply achieve and sell (Online promoted to Offline sale) under online popularization, line.
Mainly show as the medicine flow direction or the source of goods cannot be verified or follow the tracks of, authenticity of medicament difficulty is distinguished, good and bad difficulty is known, patient oneself's medication
Whether science, be rationally difficult to ensure that, lacking intimate medication guide easily, pharmacy is recommended, whether science has to promote medicine
According to being difficult to consider, pharmacist, doctor's medication are recommended, suggestion therapeutic regimen whether science, rationally do not examine or check foundation, medicine
Teacher, doctor's pharmaceutical services level cannot be weighed, and do not calculate payment or do not calculate payment the individuals such as foundation, patient, doctor, pharmacist
Privacy cannot ensure, the management such as industrial and commercial enterprises, medical institutions, doctor administrative organization and business secret cannot ensure, bad
Reaction reports not in time or omits more, and managerial personnel cannot obtain effective big data, carries out the section of marketed products
The property learned, economy and the rational evaluation of safety, it is impossible to becoming effective reference of new registration medicine, manager cannot realize
Dynamic supervision in drug flow, and protect and protect the interests of enterprise cannot practice fraud to act unfairly from selfish motives and seek profit fair and justly.Cause
This, the safety of the transparency and medicine that improve pharmaceutical production sale becomes important problem.
Summary of the invention
The invention provides a kind of Drug Safety Management system, including subscriber unit, communication unit and operation management unit,
Subscriber unit includes registering subelement, inquiry subelement, paying subelement, evaluation subelement and feedback subelement, registration
Subelement is for the information registering certification of user, and inquiry subelement is used for inquiring about medicine information and obtaining suggestion, pays son single
Unit is used for paying, and evaluates subelement and is used for medicine and provides the doctor of consultancy service, pharmacist, systems specialists to make evaluation,
Feedback subelement is used for feeding back medicining condition and reporting doubtful false flame；Operation unit includes medicine source management
Unit, drug flow condition managing subelement, organization and administration subelement, doctor manages subelement, pharmacist manages subelement,
Expert supervises subelement, and medicine source management subelement is used for recording the raw material of pharmaceutical production or significant material and being set
Being set in stock, use or used state, drug flow condition managing subelement is for carrying out the circulation status of medicine
Mark, organization and administration subelement for administrative doctor, pharmacist, friendship inspection officer and drug flow unit, the time,
Point, transaction unit total amount carry out holographic encoding management, and doctor manages subelement for providing medical services, and pharmacist manages son
Unit is used for providing medicine monitoring, pharmacy intervention and pharmacy consultation, and expert supervises subelement for managing authenticity of medicament, prison
Survey and dispose untoward reaction, evaluate drug safety.
Present invention also offers a kind of Drug Safety Management method, it is characterised in that comprise the following steps:
S1 user registers personal information, inquires about drug demand；
S2 system medicine teacher and/or online pharmacist or doctor propose to purchase medicine suggestion and points for attention, and system is cured by user, medicine
Teacher and/or the suggestion of online medicine teacher and points for attention make a choice and place an order payment；
S3 system generates selling inventory, and pharmaceutical production sales information is generated coding, and user can pass through short-message verification side
The legitimacy of formula examination medicine source；
S4 user is to the medicine after using, retailer and provides the doctor of consultancy service, pharmacist, systems specialists to make and commenting
Valency；
S5 user feedback medicining condition, its untoward reaction is examined and provides suggestion by online doctor, pharmacist；
S6 user reports doubtful false flame；
Buying raw material that S7 system provides automatically according to logistic statistics and radiopharmacy and main supplementary material production report
Carry out inquiring about, adding up, be made whether as counterfeit drug or the judgement of non-legally source medicine；
S8 expert supervises subelement and discerns the false from the genuine according to feedback and statistical information medicine, monitors disposal untoward reaction, evaluation
Drug safety.
Further, can be guarded against by following steps locking medicine to guarantee drug safety,
Find the patient feedback of untoward reaction；
Operation system is to user's confirmation, to ensure true and accurate and the availability of data；
User provides the adverse reaction rate of this medicine, points for attention, generally improves the medication warning of medicine；
Professional, with a situation arises by calling operator database adverse drug reaction, carries out instant on-line analysis,
Carry out clinical safety analysis；
A situation arises according to this medicine untoward reaction for manufacturer or new drug development mechanism, design medicine yield risk test or
Analyze, system, in time, scientifically carry out clinical drug value assessment.
Further, can be by following steps locking drug assessment to guarantee the safety that medicine uses；
Specialty research worker or supervisor carry out the safety of medicine by operation platform and effectiveness observation is looked back
Property or front Journal of Sex Research, and carry out the utilization index of medicine, Daily defined doses and defined daily dose research；
Call the big data of operation platform data base, carry out drug effectiveness, safety research, for drug registration, note again
Volume and clinical value assessment provide foundation；
The security risk that specialty research worker or supervisor bring according to the above-mentioned locking medicine source aspect that rests on a scientific basis.
Further, further comprising the steps of quick lock in that counterfeit drug is carried out:
Critical materials or adjuvant the judging rapidly and indicating for counterfeit drug of pharmaceutical production is declared by manufacturer；
Manufacturer uses native system medicine information and flows to monitoring cryptographic system, automatically generates when shipment with goods colleague's two dimension
Or three-dimension code, and for kinds of goods above the fold, it is simple to barcode scanning when receiving；
Manufacturer is that the amount of change of state every day of crucial supplementary material includes purchasing workshop in the amount of warehouse-in in storage, quantity in stock, manufacture
Storage often occurs system for varying can automatically generate outbound variation code not system to deposit (secrecy) with code form, often
It is from trend operation management unit backup；
Manufacturer be the semi-finished product amount (should be basically identical with crucial supplementary material workshop amount of storage) of each product, quantity in stock,
The variation of goods in transit amount generation every day deposits in system with two dimension or three-dimension code form, and every day is from trend operation management unit
Backup, the reasonability of Backup Data in system automatic checking system, and to abnormal pushing to manufacturer or distributor occurs
Remind verification and revise data message；
By barcode scanning input goods entry, stock and sales account system automatic after short-message verification when receiving；
Retail division automatically generates medicine with goods colleague's two dimension or three-dimension code when selling medicine generation calculation list to patient；
Patient or other medicine prison or professional inquire about medicine true and false time, by short-message verification, operation management unit is the most right
Coding and decoding, pushes medicine source and current intelligence information to the authority according to user.
When the output of the circulation of market is more than Business Issue Commodity amount, system medicine prison expert start alarm device and search for
Nearest Yao Jian law enforcement agency and personnel eject prompting, according to the geographical information state of distribution circulation, location counterfeit drug or recovery medicine
The position that product or Expired drug occur, prison law enfrocement official is timely for medicine, and verification processes.Or when finished product has been far longer than or has been more than
During current inventory quantity in stock, system medicine prison expert start alarm device and search for nearest Yao Jian law enforcement agency and people
Member, points out certain product there is counterfeit drug, Expired drug, recovery medicine or recall medicine and change the possibility that lot number lists again, according to
Compare this product stream shunting statistics and the total amount of this product of various places, clear that in somewhere pharmacy or organizational unit many
Go out the commodity that logistics is not clear, can accurately find counterfeit drug, Expired drug, recovery medicine or recall medicine and change packaging listing
Suspicion.
Native system can be plugged into the HIS system compatible of medical institutions, and the guidance of being optimized property is accustomed in the medication to doctor, and
To bad medication custom prompting, warning until rolling off the production line and cancelling right of writing a prescription on the net；Medical institutions can also be carried out fixed by native system
The behavior evaluation of phase, carries out pointing out, alerting until cancelling online doctor management and institute registration stage by stage.
The present invention can automatic fitration advertisement and artificial intervention advertisement in violation of rules and regulations in time；The medicine of unknown sources is found out in location rapidly
(counterfeit drug, Expired drug, recovery medicine)；Prevent product falsifying from disrupting the market；Improve drug safety warning, carry
High patient oneself's drug level, reduce Adverse drug events, excitation patient help each other consulting, monitoring report untoward reaction, enhancing medicine
Thing dual character recognizes, and becomes passive health education into limited paid service；Monitor rapidly strick precaution, control adverse effect；
Scientific evaluation clinical drug is worth: effectiveness and safety, by there being medical teacher accurately the reporting for main body of Professional knowledge
Outward, the patient oneself strengthened under medicine teacher checks reports, and improves the monitoring range of untoward reaction and reports the quality of data,
Provide the foundation for accurate evaluation adverse drug reaction, for drug utilization index (DUI), Daily defined doses analysis, evaluate medicine
The acceptance of product price and drug dependence tendency monitoring, the clinical value of scientific evaluation medicine, for the scientific economy of medicine
Property assessment provide objective data, for promote drug research and development produce and application optimum feedback provide condition.
Native system retains patient and selects the custom of medicine, guides patient advisory system doctor and medicine again and according to systematic science
Teacher, further according to online doctor and the paid service of pharmacist, the most correctly selects medicine and can protect patients ' privacy to greatest extent,
Being the medication of the amateur level with patient in the past, and be the medication of professional standards now, diversity is relatively big, improves medication
Rationality, decrease the drug-induced disease caused because of inappropriate medication, greatly reduce the incidence rate of untoward reaction.According to literary composition
Offering report, the morbidity of present drug-induced disease and untoward reaction rate are more than 50%.
Even if bargain link crossed by the counterfeit drug in non-legally source, Expired drug, recovery medicine, enter in patient's hands,
Because patient is to the inquiry of authenticity of medicament, medicine staining effect, invalid or untoward reaction consulting, also can find in time and position,
Alleviate density of infection and the scope of non-legally source medicine.
Compared with existing Internet pharmacy, having doctor, pharmacist professional and systems specialists more is that patient medication is checked on,
Allow the thing of professional's specialty, wrong medicine and drug risk being held in the middle of the responsibility of professional, be effectively improved
Pharmacovigilance grade.
Owing to the service of pharmacist and doctor has valency, it is connected to responsibility relevant with service quality with credit hook simultaneously,
Expert's central server of the helpfulness understanding medicine and harm, system can constantly be evaluated expert service quality and constantly come rationally
Adjust the differentiation of its service price.
In order to preferably implement drug safety supervision, pharmacy corporation is actively added anti-counterfeit drug alliance, is guaranteeing Enterprise business
On the premise of secret is to be fully ensured, pharmacy corporation supplementary material dynamic data is stored the most automatically, and primary listings has raw material
Drug Storage storage, workshop usage amount and usage amount, finished product is also set three kinds of states: in manufacturer's quantity in stock, transport
Amount of medicament (including wholesale distribution transport and stock), retail counter storage, make enterprise scien`, accurately by system feedback
Plan is thrown in the decision-making production schedule in time, market；
Health administration department is while strengthening scientific management, and refinement classification of diseases management, at non-medical organization
The disease put, it is allowed to doctor carries out diagnosis and treatment and consultancy service on the net is on the basis of OTC prescription scientific management, perfect
Medicine, classification of diseases manage, the scope of approval doctor's online service, and allowance prescription drugs, poison fiber crops essence put medicine by existing management
The online evolution of program purchases medicine；Hospital and doctor agree to that patient uses that source is legal to be bought medicine, hospital and doctor by oneself and can collect one
Fixed (the 10% of total value, doctor, hospital 8:2)；Medicine can directly enter from manufacturer in hospital, and hospital encourages doctor to pass through HIS
System is write a prescription, and notifies that patient purchases medicine on the net, and doctor can collect certain consultation fee；The online evolution of doctor is conducive to improving hospital
Popularity, improves the assessment to doctor's service level, improves level of rational use of drugs；Hospital pharmacy is managed also can be with hospital
Independent, technically can be instructed by it.Imitation medicine quality conformance evaluation is generally admitted and is implemented.
The present invention can carry out precisely handle to the volume of production of the most completed volume of production, volume of production in workshop and deposit
Hold, the supplementary material in circulation and medicine be accurately positioned tracking strict protection business secret, implement circulating label private mark system,
I.e. protect business secret and prevent again commodity falsifying adverse current, also reduce manufacturing enterprise simultaneously and blindly produce and sell enterprise
Blindly throwing in product, cause commodity stocks to overstock, occupation of capital rate increases, merchandise cost increases, consumer's burden aggravation
Deng.Conveniently, scientifically realize basic medicine, medical insurance medicine, the Classification Management of new agriculture conjunction medicine, also can be to OTC, place
Side's medicine and poison, fiber crops, essence, put medicine and realize dynamic supervision, the most accurate dispatches emergency medicine.System is automatically to circulation medicine
Generate accurate geography information, owner and transport director's private mark information, each via terminal authentication letter biology when examining goods
After breath, could decode, each signed electronically handing-over.Each link i.e. protects privacy to also ensure that accountability is traced to the source, and blocks
The non-legally source listing such as medicine counterfeit drug, it is ensured that drug flow, use order, ensure that drug safety, it is ensured that medicine
Product science, economy, the verity of safety evaluatio data and promptness.
Accompanying drawing explanation
Fig. 1 is a kind of Drug Safety Management system structure schematic diagram.
Fig. 2 is a kind of Drug Safety Management method flow diagram.
Detailed description of the invention
The invention provides a kind of Drug Safety Management system, including subscriber unit 1, communication unit 2 and operation management list
Unit 3, subscriber unit includes registering subelement 11, inquiry subelement 12, paying subelement 13, evaluation subelement 14 and
Feedback subelement 15, registration subelement for the information registering certification of user, inquiry subelement be used for inquiring about medicine information and
Obtain suggestion, pay subelement be used for paying, evaluate subelement for medicine and provide the doctor of consultancy service, pharmacist,
Systems specialists makes evaluation, and feedback subelement is used for feeding back medicining condition and reporting doubtful false flame；Operation unit
Including medicine source management subelement 31, drug flow condition managing subelement 32, organization and administration subelement 33, doctor
Manage subelement 34, pharmacist manages subelement 35, expert supervises subelement 36, and medicine source management subelement is used for remembering
The record raw material of pharmaceutical production or significant material and set it to stock, use in or used state, drug flow shape
State management subelement for the circulation status of medicine is identified, organization and administration subelement for administrative doctor, pharmacist,
Handing over inspection officer and drug flow unit, time, place, transaction unit total amount to carry out holographic encoding management, doctor manages
Subelement is used for providing medical services, pharmacist to manage subelement for providing medicine monitoring, pharmacy intervention and pharmacy consultation,
Expert supervises subelement for managing authenticity of medicament, monitoring disposal untoward reaction, evaluating drug safety.
Present invention also offers a kind of Drug Safety Management method, it is characterised in that comprise the following steps:
S1 user registers personal information, inquires about drug demand；
S2 system medicine teacher and/or online pharmacist or doctor propose to purchase medicine suggestion and points for attention, and system is cured by user, medicine
Teacher and/or the suggestion of online medicine teacher and points for attention make a choice and place an order payment；
S3 system generates selling inventory, and pharmaceutical production sales information is generated coding, and user can pass through short-message verification side
The legitimacy of formula examination medicine source；
S4 user is to the medicine after using, retailer and provides the doctor of consultancy service, pharmacist, systems specialists to make and commenting
Valency；
S5 user feedback medicining condition, its untoward reaction is examined and provides suggestion by online doctor, pharmacist；
S6 user reports doubtful false flame；
Buying raw material that S7 system provides automatically according to logistic statistics and radiopharmacy and main supplementary material production report
Carry out inquiring about, adding up, be made whether as counterfeit drug or the judgement of non-legally source medicine；
S8 expert supervises subelement and discerns the false from the genuine according to feedback and statistical information medicine, monitors disposal untoward reaction, evaluation
Drug safety.
Further, can be guarded against by following steps locking medicine to guarantee drug safety,
Find the patient feedback of untoward reaction；
Operation system is to user's confirmation, to ensure true and accurate and the availability of data；
User provides the adverse reaction rate of this medicine, points for attention, generally improves the medication warning of medicine；
Professional, with a situation arises by calling operator database adverse drug reaction, carries out instant on-line analysis,
Carry out clinical safety analysis；
A situation arises according to this medicine untoward reaction for manufacturer or new drug development mechanism, design medicine yield risk test or
Analyze, system, in time, scientifically carry out clinical drug value assessment.
Further, can be by following steps locking drug assessment to guarantee the safety that medicine uses；
Specialty research worker or supervisor carry out the safety of medicine by operation platform and effectiveness observation is looked back
Property or front Journal of Sex Research, and carry out the utilization index of medicine, Daily defined doses and defined daily dose research；
Call the big data of operation platform data base, carry out drug effectiveness, safety research, for drug registration, note again
Volume and clinical value assessment provide foundation；
The security risk that specialty research worker or supervisor bring according to the above-mentioned locking medicine source aspect that rests on a scientific basis.
Further, further comprising the steps of quick lock in that counterfeit drug is carried out:
Critical materials or adjuvant the judging rapidly and indicating for counterfeit drug of pharmaceutical production is declared by manufacturer；
Manufacturer uses native system medicine information and flows to monitoring cryptographic system, automatically generates when shipment with goods colleague's two dimension
Or three-dimension code, and for kinds of goods above the fold, it is simple to barcode scanning when receiving；
Manufacturer is that the amount of change of state every day of crucial supplementary material includes purchasing workshop in the amount of warehouse-in in storage, quantity in stock, manufacture
Storage often occurs system for varying can automatically generate outbound variation code not system to deposit (secrecy) with code form, often
It is from trend operation management unit backup；
Manufacturer be the semi-finished product amount (should be basically identical with crucial supplementary material workshop amount of storage) of each product, quantity in stock,
The variation of goods in transit amount generation every day deposits in system with two dimension or three-dimension code form, and every day is from trend operation management unit
Backup, the reasonability of Backup Data in system automatic checking system, and to abnormal pushing to manufacturer or distributor occurs
Remind verification and revise data message；
By barcode scanning input goods entry, stock and sales account system automatic after short-message verification when receiving；
Retail division automatically generates medicine with goods colleague's two dimension or three-dimension code when selling medicine generation calculation list to patient；
Patient or other medicine prison or professional inquire about medicine true and false time, by short-message verification, operation management unit is the most right
Coding and decoding, pushes medicine source and current intelligence information to the authority according to user.
When the output of the circulation of market is more than Business Issue Commodity amount, system medicine prison expert start alarm device and search for
Nearest Yao Jian law enforcement agency and personnel eject prompting, according to the geographical information state of distribution circulation, location counterfeit drug or recovery medicine
The position that product or Expired drug occur, prison law enfrocement official is timely for medicine, and verification processes.Or when finished product has been far longer than or has been more than
During current inventory quantity in stock, system medicine prison expert start alarm device and search for nearest Yao Jian law enforcement agency and people
Member, points out certain product there is counterfeit drug, Expired drug, recovery medicine or recall medicine and change the possibility that lot number lists again, according to
Compare this product stream shunting statistics and the total amount of this product of various places, clear that in somewhere pharmacy or organizational unit many
Go out the commodity that logistics is not clear, can accurately find counterfeit drug, Expired drug, recovery medicine or recall medicine and change packaging listing
Suspicion.
Native system can be plugged into the HIS system compatible of medical institutions, and the guidance of being optimized property is accustomed in the medication to doctor, and
To bad medication custom prompting, warning until rolling off the production line and cancelling right of writing a prescription on the net；Medical institutions can also be carried out fixed by native system
The behavior evaluation of phase, carries out pointing out, alerting until cancelling online doctor management and institute registration stage by stage.
Above-mentioned is only preferred scheme and case study on implementation, certainly can not limit the interest field of the present invention with this,
Therefore the equivalent variations made according to scope of the present invention patent, still belongs to the scope that the present invention is contained.
Claims (2)
1. a Drug Safety Management system, it is characterised in that: include subscriber unit (1), communication unit (2) and fortune
Battalion administrative unit (3), subscriber unit include register subelement (11), inquiry subelement (12), pay subelement (13),
Evaluating subelement (14) and feedback subelement (15), registration subelement is for the information registering certification of user, inquiry
Unit is used for inquiring about medicine information and obtaining suggestion, pays subelement and is used for paying, and evaluates subelement and is used for medicine and carries
Making evaluation for the doctor of consultancy service, pharmacist, systems specialists, feedback subelement is used for feeding back medicining condition and report is doubted
Like false flame；Operation unit includes medicine source management subelement (31), drug flow condition managing subelement
(32), organizing subelement (33), doctor manages subelement (34), pharmacist manages subelement (35), Zhuan Jiajian
Unit of pipe (36), medicine source management subelement is used for recording the raw material of pharmaceutical production or significant material and being set
Being set in stock, use or used state, drug flow condition managing subelement is for carrying out the circulation status of medicine
Mark, organization and administration subelement for administrative doctor, pharmacist, friendship inspection officer and drug flow unit, the time,
Point, transaction unit total amount carry out holographic encoding management, and doctor manages subelement for providing medical services, and pharmacist manages son
Unit is used for providing medicine monitoring, pharmacy intervention and pharmacy consultation, and expert supervises subelement for managing authenticity of medicament, prison
Survey and dispose untoward reaction, evaluate drug safety.
2. a Drug Safety Management method, it is characterised in that comprise the following steps:
S1 user registers personal information, inquires about drug demand；
S2 system medicine teacher and/or online pharmacist or doctor propose to purchase medicine suggestion and points for attention, and system is cured by user, medicine
Teacher and/or the suggestion of online medicine teacher and points for attention make a choice and place an order payment；
S3 system generates selling inventory, and pharmaceutical production sales information is generated coding, and user can pass through short-message verification side
The legitimacy of formula examination medicine source；
S4 user is to the medicine after using, retailer and provides the doctor of consultancy service, pharmacist, systems specialists to make and commenting
Valency；
S5 user feedback medicining condition, its untoward reaction is examined and provides suggestion by online doctor, pharmacist；
S6 user reports doubtful false flame；
Buying raw material that S7 system provides automatically according to logistic statistics and radiopharmacy and main supplementary material production report
Carry out inquiring about, adding up, be made whether as counterfeit drug or the judgement of non-legally source medicine；
S8 expert supervises subelement and discerns the false from the genuine according to feedback and statistical information medicine, monitors disposal untoward reaction, evaluation
Drug safety.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2015101200847 | 2015-03-18 | ||
| CN201510120084 | 2015-03-18 | ||
| CN201510233469 | 2015-05-10 | ||
| CN2015102334694 | 2015-05-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105989506A true CN105989506A (en) | 2016-10-05 |
Family
ID=57040312
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510873882.7A Pending CN105989506A (en) | 2015-03-18 | 2015-12-02 | Drug safety management system and method |
| CN201510875566.3A Pending CN105989448A (en) | 2015-03-18 | 2015-12-02 | Intelligent drug safety lock |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510875566.3A Pending CN105989448A (en) | 2015-03-18 | 2015-12-02 | Intelligent drug safety lock |
Country Status (1)
| Country | Link |
|---|---|
| CN (2) | CN105989506A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107194707A (en) * | 2017-05-31 | 2017-09-22 | 江苏密斯欧智能科技有限公司 | Drug safety intelligent platform |
| CN107330284A (en) * | 2017-07-06 | 2017-11-07 | 上海观谷科技有限公司 | Drug information management methods, devices and systems |
| CN107463788A (en) * | 2017-08-21 | 2017-12-12 | 上海观谷科技有限公司 | Smart cloud pharmacy system and its control method and server |
| CN109461484A (en) * | 2018-11-12 | 2019-03-12 | 上海观谷科技有限公司 | Medicine management system and method |
| CN109979111A (en) * | 2019-03-26 | 2019-07-05 | 哈尔滨金鑫海文化传媒有限公司 | One kind is self-service to sell medicine system |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109615538A (en) * | 2018-12-13 | 2019-04-12 | 平安医疗健康管理股份有限公司 | Social security violation detection method, device, equipment and computer storage medium |
| CN111177516A (en) * | 2019-12-30 | 2020-05-19 | 嘉兴太美医疗科技有限公司 | Medication alert system and method of processing feedback data thereof |
| TWI801233B (en) * | 2022-05-04 | 2023-05-01 | 員榮醫療社團法人員榮醫院 | Remote consultation medication system |
| CN115600847B (en) * | 2022-09-09 | 2023-05-26 | 芯电智联(北京)科技有限公司 | Electronic cigarette after-sale inspection system |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201892974U (en) * | 2010-07-09 | 2011-07-06 | 北京市药品监督管理局东城分局 | Drug security information service system |
| CN102496100A (en) * | 2011-12-09 | 2012-06-13 | 无锡识凌科技有限公司 | Long-distance medicine supply system and method |
| CN102521773A (en) * | 2011-12-29 | 2012-06-27 | 重庆大学 | Electronic-commerce system for medicine |
| CN103198409A (en) * | 2013-03-28 | 2013-07-10 | 福州天虹电脑科技有限公司 | Off-site regulation method used for medicine circulation |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090001706A1 (en) * | 2007-06-28 | 2009-01-01 | Huber W Rene | Self-adhesive message panel |
| CN103729821A (en) * | 2014-01-23 | 2014-04-16 | 黑龙江大学 | Intelligent medicine cabinet system |
| CN203724478U (en) * | 2014-02-27 | 2014-07-23 | 重庆柚瓣科技有限公司 | Intelligent medicine chest |
-
2015
- 2015-12-02 CN CN201510873882.7A patent/CN105989506A/en active Pending
- 2015-12-02 CN CN201510875566.3A patent/CN105989448A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN201892974U (en) * | 2010-07-09 | 2011-07-06 | 北京市药品监督管理局东城分局 | Drug security information service system |
| CN102496100A (en) * | 2011-12-09 | 2012-06-13 | 无锡识凌科技有限公司 | Long-distance medicine supply system and method |
| CN102521773A (en) * | 2011-12-29 | 2012-06-27 | 重庆大学 | Electronic-commerce system for medicine |
| CN103198409A (en) * | 2013-03-28 | 2013-07-10 | 福州天虹电脑科技有限公司 | Off-site regulation method used for medicine circulation |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107194707A (en) * | 2017-05-31 | 2017-09-22 | 江苏密斯欧智能科技有限公司 | Drug safety intelligent platform |
| CN107330284A (en) * | 2017-07-06 | 2017-11-07 | 上海观谷科技有限公司 | Drug information management methods, devices and systems |
| CN107463788A (en) * | 2017-08-21 | 2017-12-12 | 上海观谷科技有限公司 | Smart cloud pharmacy system and its control method and server |
| CN109461484A (en) * | 2018-11-12 | 2019-03-12 | 上海观谷科技有限公司 | Medicine management system and method |
| CN109979111A (en) * | 2019-03-26 | 2019-07-05 | 哈尔滨金鑫海文化传媒有限公司 | One kind is self-service to sell medicine system |
Also Published As
| Publication number | Publication date |
|---|---|
| CN105989448A (en) | 2016-10-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105989506A (en) | Drug safety management system and method | |
| Cohen et al. | Corruption and pharmaceuticals: Strengthening good governance to improve access | |
| Nguyen et al. | Pharmaceutical policy in Vietnam | |
| DeKieffer | Trojan drugs: counterfeit and mislabeled pharmaceuticals in the legitimate market | |
| Valverde | Corporate responsibility and pharmaceutical fraud | |
| Handfield | Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead | |
| Cohen et al. | Improving transparency in pharmaceutical systems: strengthening critical decision points against corruption | |
| Garrett et al. | Leveling the playing field in the pharmacy benefit management industry | |
| Chinwendu | The fight against fake drugs by NAFDAC in Nigeria | |
| Mitchell | The potential for self-interested behavior by pharmaceutical manufacturers through vertical integration with pharmacy benefit managers: The need for a new regulatory approach | |
| Rosoff | The changing face of pharmacy benefits management: information technology pursues a grand mission | |
| Angarola et al. | The prescription drug marketing act: A solution in search of a problem? | |
| Satterlee et al. | Exemption-Based Franchising: Are You Playing a Minefield | |
| Dow et al. | Legal and Compliance Considerations When Bringing Cellular Therapies to Market. | |
| Butenko | New falsified medicinal products’ distribution prevention regulation: legal issues and good distribution practice for pharmaceutical companies | |
| World Health Organization | Measuring transparency to improve good governance in the public pharmaceutical sector: Pakistan | |
| Barrett | Sales, Marketing and Advertising | |
| Said | Effect of counterfeit drugs on distribution of pharmaceutical products in Mombasa county, Kenya | |
| Mulcahy et al. | Prescription Drug Supply Chains | |
| Fedotova et al. | Protection of life and health of citizens in the sphere of production and circulation of medicines and medical products: a legal aspect | |
| Mello | NASHP’s proposal for protecting consumers from prescription drug price gouging | |
| Yazi et al. | Research on dynamic mechanisms for adjusting China's reimbursable drug list | |
| Palafox et al. | A qualitative assessment of the private sector antimalarial distribution chain in Nigeria, 2009 | |
| Mahugh | Lost in the Gray: Navigating the Problem of Pharmaceuticals in the Gray Market | |
| Moss | Healthcare Intermediaries: Competition and Healthcare Policy at Loggerheads? |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20200318 Address after: 510075 Room 411, No. 83, Xianlie Middle Road, Yuexiu District, Guangzhou City, Guangdong Province (only for office use) Applicant after: Masson Technology (Guangzhou) Co., Ltd Applicant after: Liu Zhenmin Address before: Baiyun District of Guangzhou City, Guangdong province 510420 Baiyun Avenue cloud top Spring Street No. 7 room A5-1206 Applicant before: Liu Zhenmin |
|
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161005 |